BSE filing, NSE: RELINFRA. Summary written from the filing by ALFA Finder's alert engine.
Reliance Infrastructure Ltd: key numbers
- Share price
- ₹46.58
- Market cap
- ₹1,903 Cr
- Revenue (annual)
- ₹20,441 Cr
- Net profit (annual)
- ₹2,900 Cr
- P/E (TTM)
- 0.6×Sector 21.4×
- Promoter holding
- 19.05%+0.00% QoQ
- FII holding
- 4.83%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Reliance Infrastructure Ltd
All →Reliance Infrastructure Legal & Regulatory
Reliance Infrastructure Limited has been named as an accused in a second chargesheet filed by the CBI regarding the Reliance Home Finance Limited matter.
Reliance Infrastructure Adverse Business Impact
Reliance Infrastructure's subsidiary, MMOPL, had its Master Restructuring Agreement (MRA) with NARCL revoked due to unfulfilled conditions precedent. The financial impact currently remains unascertainable.
Reliance Infrastructure Insolvency Petition
IIFC (UK) filed an IBC Section 7 petition against Reliance Infrastructure's subsidiary, MMOPL, at NCLT Mumbai claiming approximately USD 182 Million.
- Value
- ₹18.20 Cr
Reliance Infrastructure Insolvency Petition
Reliance Infrastructure's JV, Mumbai Metro One, faces an IBC petition from IIFC for ~USD 182 million. NARCL also revoked a debt restructuring agreement for the JV.
- Value
- ₹1,747 Cr
Reliance Infrastructure Legal & Regulatory
Reliance Infrastructure has been named as a proposed accused in a Directorate of Enforcement complaint involving an alleged amount of Rs. 179.66 Crore.
- Value
- ₹179.7 Cr
Reliance Infrastructure ED Probe / Tax Survey
Reliance Infrastructure has been named as a proposed accused in an Enforcement Directorate complaint under the Prevention of Money Laundering Act, involving Rs. 179.66 crore.
- Value
- ₹179.7 Cr
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.